Costanza Savino

1.7k total citations
8 papers, 757 citations indexed

About

Costanza Savino is a scholar working on Neurology, Oncology and Hematology. According to data from OpenAlex, Costanza Savino has authored 8 papers receiving a total of 757 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Neurology, 3 papers in Oncology and 3 papers in Hematology. Recurrent topics in Costanza Savino's work include Erythropoietin and Anemia Treatment (3 papers), Pain Mechanisms and Treatments (2 papers) and Botulinum Toxin and Related Neurological Disorders (2 papers). Costanza Savino is often cited by papers focused on Erythropoietin and Anemia Treatment (3 papers), Pain Mechanisms and Treatments (2 papers) and Botulinum Toxin and Related Neurological Disorders (2 papers). Costanza Savino collaborates with scholars based in Italy, United States and Switzerland. Costanza Savino's co-authors include Roberto Bianchi, Giuseppe Lauria, Guido Cavaletti, Raffaella Lombardi, M. Borgna, Pietro Ghezzi, Michael Brines, Anthony Cerami, N Oggioni and Gabriella Nicolini and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Clinical Cancer Research and European Journal of Neuroscience.

In The Last Decade

Costanza Savino

8 papers receiving 736 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Costanza Savino Italy 7 267 206 204 160 103 8 757
Oliver Herrmann Germany 17 128 0.5× 100 0.5× 510 2.5× 120 0.8× 156 1.5× 29 1.3k
Preet G. S. Makker Australia 12 361 1.4× 57 0.3× 166 0.8× 290 1.8× 92 0.9× 20 737
Zhaoqiang Cui China 14 101 0.4× 63 0.3× 615 3.0× 81 0.5× 94 0.9× 26 1.2k
Jie Yin China 16 72 0.3× 66 0.3× 357 1.8× 108 0.7× 83 0.8× 73 1.1k
Dursun Gündüz Germany 20 181 0.7× 50 0.2× 402 2.0× 63 0.4× 88 0.9× 37 899
Cendrine Cabou France 17 160 0.6× 146 0.7× 343 1.7× 69 0.4× 92 0.9× 28 978
Betty Pat United States 19 200 0.7× 113 0.5× 358 1.8× 56 0.3× 37 0.4× 39 1.2k
Rosita Stanzione Italy 23 247 0.9× 68 0.3× 574 2.8× 68 0.4× 63 0.6× 65 1.5k
Eva Geuß Germany 10 121 0.5× 88 0.4× 231 1.1× 32 0.2× 45 0.4× 10 751
Justin Massengale United States 7 72 0.3× 112 0.5× 296 1.5× 46 0.3× 49 0.5× 10 800

Countries citing papers authored by Costanza Savino

Since Specialization
Citations

This map shows the geographic impact of Costanza Savino's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Costanza Savino with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Costanza Savino more than expected).

Fields of papers citing papers by Costanza Savino

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Costanza Savino. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Costanza Savino. The network helps show where Costanza Savino may publish in the future.

Co-authorship network of co-authors of Costanza Savino

This figure shows the co-authorship network connecting the top 25 collaborators of Costanza Savino. A scholar is included among the top collaborators of Costanza Savino based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Costanza Savino. Costanza Savino is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Savino, Costanza, Pier Giuseppe Pelicci, & Marco Giorgio. (2013). The P66Shc/Mitochondrial Permeability Transition Pore Pathway Determines Neurodegeneration. Oxidative Medicine and Cellular Longevity. 2013. 1–7. 37 indexed citations
2.
Su, Kimmy, Costanza Savino, Gail Marracci, et al.. (2012). Genetic inactivation of the p66 isoform of ShcA is neuroprotective in a murine model of multiple sclerosis. European Journal of Neuroscience. 35(4). 562–571. 28 indexed citations
3.
Bianchi, Roberto, Michael Brines, Giuseppe Lauria, et al.. (2006). Protective Effect of Erythropoietin and Its Carbamylated Derivative in Experimental Cisplatin Peripheral Neurotoxicity. Clinical Cancer Research. 12(8). 2607–2612. 80 indexed citations
4.
Savino, Costanza, Rosetta Pedotti, Fulvio Baggi, et al.. (2005). Delayed administration of erythropoietin and its non-erythropoietic derivatives ameliorates chronic murine autoimmune encephalomyelitis. Journal of Neuroimmunology. 172(1-2). 27–37. 93 indexed citations
5.
Lauria, Giuseppe, Raffaella Lombardi, M. Borgna, et al.. (2005). Intraepidermal nerve fiber density in rat foot pad: neuropathologic–neurophysiologic correlation. Journal of the Peripheral Nervous System. 10(2). 202–208. 132 indexed citations
6.
Fiordaliso, Fabio, Lidia Staszewsky, Ivan Cuccovillo, et al.. (2004). Antioxidant treatment attenuates hyperglycemia-induced cardiomyocyte death in rats. Journal of Molecular and Cellular Cardiology. 37(5). 959–968. 170 indexed citations
7.
Borgna, M., Raffaella Lombardi, Giuseppe Lauria, et al.. (2004). Intraepidermal innervation and tail nerve conduction velocity in neurotoxicity models: results of a correlation study in normal and pathological conditions. Journal of the Peripheral Nervous System. 9(2). 104–105. 3 indexed citations
8.
Bianchi, Roberto, Belgin Büyükakıllı, Michael Brines, et al.. (2004). Erythropoietin both protects from and reverses experimental diabetic neuropathy. Proceedings of the National Academy of Sciences. 101(3). 823–828. 214 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026